
MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB
Geneva, 3rd May, 2022 – Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi












